focus -WSS

focus

author：fashion 2025-09-30 18:59:17 - browse：6

Adobe

More than a year ago, Kaiser Permanente made waves when it said it was creating a new, sprawling entity of nonprofit hospitals and doctors with Geisinger as its first takeover — the latest example of health care companies bulking up in an already highly consolidated industry.

Nothing has happened since then, at least publicly. Geisinger’s 10 hospitals and 1,700 employed physicians are now officially part of the group, known as Risant Health. Kaiser, which is both a health insurance company and a network of providers, said it wants to add at least five to six more health systems by 2028.

Those other organizations are still a mystery. But recent financial reports show a handful of systems that have been on the same shaky trajectory as Geisinger and could find themselves in Kaiser’s crosshairs. Patients and local communities have a lot at stake if their health system gets gobbled up by Kaiser; it’s still unclear how this unique structure will alter costs or quality of care.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

focus

WSS

Readout Newsletter: Bristol, Sangamo, Gilead, and more

A preacher's new calling: Diversifying neuroscience research

Steward Health Care Massachusetts hospitals face fiscal disaster

Arena BioWorks launches in Cambridge to speed drug discovery

Ebola: Gilead Sciences antiviral shows promise as new treatment

Why scientists need input from humanists on sensitive research

Wikipedia

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

explore

Medical leaders decry Supreme Court decision on affirmative action

John Green on his newest strategy for fighting tuberculosis

Moonlake's readout produced a cash windfall. Risks remain

Stories you might have missed in 2023: health, science, medicine

Activists slam private health insurers over coverage restrictions

Ebola: Gilead Sciences antiviral shows promise as new treatment

United colonoscopy coverage change 'may cost lives,' doctors say

Hospital chaplains balance Covid safety with patients’ spiritual needs

Supreme Court strikes down use of affirmative action

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

focus

Readout Newsletter: CAR

JPM pitch from hospitals? Revenue streams outside of patient care

Life science postdocs should get big pay hike, NIH panel says

EPA limits use of carcinogenic gas for sterilizing medical devices

Pushing for an NIH office for post

Why depression after traumatic brain injury is distinct

focus

focus

entertainment

leisure time